Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin as Adjuvant Therapy in Relapsing-Remitting Multiple Sclerosis
NCT04178980Phase 1Unknown
- Sponsor
- Assiut University
- Start
- Jan 2020
- Primary completion
- Jan 2022
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in relapsing-remitting multiple sclerosis (RRMS) comparing Simvastatin Arm with Placebo Arm (2 arms). Primary endpoint: Expanded Disability Status Scale at 24 months. Status: unknown.
02
Drugs
simvastatin
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT04178980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04178980.